OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa
Emma Reece, Pedro H. de Almeida Bettio, J. A. A. Renwick
Antibiotics (2021) Vol. 10, Iss. 7, pp. 827-827
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents
Eduarda Silva, J. A. Teixeira, Maria Olívia Pereira, et al.
Phytomedicine (2023) Vol. 119, pp. 154973-154973
Open Access | Times Cited: 30

Interkingdom interactions between Pseudomonas aeruginosa and Candida albicans affect clinical outcomes and antimicrobial responses
Lisa Juliane Kahl, Nina Stremmel, M. Alejandra Esparza-Mora, et al.
Current Opinion in Microbiology (2023) Vol. 75, pp. 102368-102368
Closed Access | Times Cited: 20

Advances in bacteriophage-mediated strategies for combating polymicrobial biofilms
Marta Gliźniewicz, Dominika Miłek, Patrycja Olszewska, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 9

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
Francesca Saluzzo, Luca Riberi, Barbara Messore, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1243-1243
Open Access | Times Cited: 31

Competition quenching strategies reduce antibiotic tolerance in polymicrobial biofilms
Bram Lories, Tom E. R. Belpaire, Bart Smeets, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
Gillian McDermott, Aaron M. Walsh, Fiona Crispie, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3893-3893
Open Access | Times Cited: 2

Exploring the dynamics of mixed-species biofilms involving Candida spp. and bacteria in cystic fibrosis
Karima Gourari-Bouzouina, Zahia Boucherit‐Otmani, Noureddine Halla, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 6
Closed Access | Times Cited: 2

Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections
Tegan M. Hibbert, Marvin Whiteley, Stephen A. Renshaw, et al.
Critical Reviews in Microbiology (2023), pp. 1-16
Open Access | Times Cited: 7

Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus
Laura Camus, Paul Briaud, François Vandenesch, et al.
Advances in experimental medicine and biology (2022), pp. 397-424
Closed Access | Times Cited: 12

CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
Min Wu, Jeng‐Haur Chen
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 1

Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans
Ziqi Wang, Qi Zhang, Haoying Zhang, et al.
Critical Reviews in Microbiology (2024), pp. 1-15
Closed Access | Times Cited: 1

Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies
Mayram Hacıoğlu, Fatıma Nur Yılmaz, Hande İpek Yetke, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access | Times Cited: 1

SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6

Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota
Pok-Man Ho, Rahan Rudland Nazeer, Martin Welch
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3

Pseudomonas aeruginosa in the Cystic Fibrosis Lung
John A. King, Ronan A. Murphy, Jane C. Davies
Advances in experimental medicine and biology (2022), pp. 347-369
Closed Access | Times Cited: 6

The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis
Anton Barucha, Renan Marrichi Mauch, Franziska Duckstein, et al.
Expert Review of Respiratory Medicine (2022) Vol. 16, Iss. 7, pp. 723-735
Closed Access | Times Cited: 5

Aspergillus fumigatus Supernatants Disrupt Bronchial Epithelial Monolayers: Potential Role for Enhanced Invasion in Cystic Fibrosis
Katie Dunne, Emma Reece, Siobhán McClean, et al.
Journal of Fungi (2023) Vol. 9, Iss. 4, pp. 490-490
Open Access | Times Cited: 2

The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity ofPseudomonas aeruginosaPopulations in Cystic Fibrosis Lung Infection
Jelly Vanderwoude, Sheyda Azimi, Timothy D. Read, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Synergy Between Pseudomonas aeruginosa Filtrates And Voriconazole Against Aspergillus fumigatus Biofilm Is Less for Mucoid Isolates From Persons With Cystic Fibrosis
Gabriele Sass, Julianne J. Marsh, Pallabi Shrestha, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 4

Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis
Felipe A. Simão, Mila Muraro de Almeida, Heloisa da Silva Rosa, et al.
Brazilian Journal of Microbiology (2024) Vol. 55, Iss. 2, pp. 1415-1425
Closed Access

Page 1 - Next Page

Scroll to top